Fresenius Medical Care AG & Co. KGaA Q4 Earnings Call Highlights

Giza also said earnings per share increased 44% , attributing the rise to earnings strength and the impact of an accelerated share buyback program. Net leverage improved to 2.5x , which she described as the bottom end of the company’s lowered target corridor, down from 3.4x at the end of 2022.Giza said the company closed 2025 with “strong results,” including organic revenue growth of 8% . She reported that reported operating income grew 31% and reported net income rose 82% , while operating income excluding ...